PARIS, April 16 (Reuters) - BioAlliance Pharma has won U.S. marketing approval for its oral anti-fungal tablet miconazole Lauriad, making it the first treatment for the French biotechnology company to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback